About 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide
1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide (PubChem CID 123341112) has the molecular formula C23H28F4N5O3S+
and a molecular weight of 530.57 g/mol. Its IUPAC name is 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide.
Molecular Properties
| Compound Name | 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide |
| PubChem CID | 123341112 |
| Molecular Formula | C23H28F4N5O3S+ |
| Molecular Weight | 530.57 g/mol |
| Exact Mass | 530.18 |
| IUPAC Name | 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide |
| SMILES | [H]/N=C/C1CC(N2CCCC2CF)CCC1[N+]1=C(Nc2ccc(S(=O)(=O)C(F)(F)F)cc2)C(C(N)=O)=C1 |
| InChI | InChI=1S/C23H27F4N5O3S/c24-11-17-2-1-9-31(17)16-5-8-20(14(10-16)12-28)32-13-19(21(29)33)22(32)30-15-3-6-18(7-4-15)36(34,35)23(25,26)27/h3-4,6-7,12-14,16-17,20,28H,1-2,5,8-11H2,(H2,29,33)/p+1/b28-12+ |
| InChIKey | VUXQDUMCROFNJN-KVSWJAHQSA-O |
| XLogP | 2.81 |
| TPSA | 119.36 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 530.57 |
| LogP ≤ 5 | 2.81 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Analyze 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide?
The IUPAC name of 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide (CID 123341112) is 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide.
What is the SMILES notation for 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide?
The canonical SMILES for 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide is [H]/N=C/C1CC(N2CCCC2CF)CCC1[N+]1=C(Nc2ccc(S(=O)(=O)C(F)(F)F)cc2)C(C(N)=O)=C1.
What is the InChIKey of 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide?
The InChIKey is VUXQDUMCROFNJN-KVSWJAHQSA-O. The full InChI is InChI=1S/C23H27F4N5O3S/c24-11-17-2-1-9-31(17)16-5-8-20(14(10-16)12-28)32-13-19(21(29)33)22(32)30-15-3-6-18(7-4-15)36(34,35)23(25,26)27/h3-4,6-7,12-14,16-17,20,28H,1-2,5,8-11H2,(H2,29,33)/p+1/b28-12+.
What are the key properties of 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide?
1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide has a molecular weight of 530.57 g/mol, XLogP of 2.81, 7 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[4-[2-(fluoromethyl)pyrrolidin-1-yl]-2-methanimidoylcyclohexyl]-2-[4-(trifluoromethylsulfonyl)anilino]azet-1-ium-3-carboxamide is sourced from PubChem (CID 123341112), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).